Ethylatropine Bromide as a Peripherally Restricted Muscarinic Antagonist. [PDF]
ACS Chem Neurosci, 2017 Rojas A +3 more
europepmc +1 more source
Comparative Causal Analysis of the Effects of Long-Acting Muscarinic Antagonist Versus No Long-Acting Bronchodilator Use on Readmission or Mortality After Hospitalization for Chronic Obstructive Pulmonary Disease. [PDF]
Drugs Real World Outcomes, 2020 Roberts MH, Mapel DW, Petersen H.
europepmc +1 more source
Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate. [PDF]
Chronic Obstr Pulm Dis, 2019 Mahler DA +5 more
europepmc +1 more source
Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD. [PDF]
Int J Chron Obstruct Pulmon Dis, 2018 D'Urzo AD, Kardos P, Wiseman R.
europepmc +1 more source
Once-daily tiotropium and olodaterol fixed-dose combination via the Respimat® improves outcomes versus mono-components in COPD in two 1-year studies [PDF]
, 2014 Buhl, R +12 more
core +1 more source
Muscarinic antagonist effects on experimental chick myopia
Experimental Eye Research, 1991 R A, Stone, T, Lin, A M, Laties
openaire +2 more sources
Voiding Behavior and Efferent Bladder Function Altered in Mice Following Social Defeat but Not Witness Trauma [PDF]
, 2020 Chess-Williams, Russ +3 more
core +1 more source
A Muscarinic Antagonist Reduces Airway Inflammation and Bronchoconstriction Induced by Ambient Particulate Matter in a Mouse Model of Asthma. [PDF]
Int J Environ Res Public Health, 2018 Kurai J +5 more
europepmc +1 more source
Glycopyrrolate/eFlow CS: The First Nebulized Long-Acting Muscarinic Antagonist Approved to Treat Chronic Obstructive Pulmonary Disease. [PDF]
Ann Pharmacother, 2019 Pleasants RA.
europepmc +1 more source